| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/30/2004 | US6713485 Antiproliferative agents; side effect reduction |
| 03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 03/30/2004 | US6713074 Cosmetic composition and method |
| 03/30/2004 | US6712617 Methods of preventing UVB-induced skin damage |
| 03/30/2004 | CA2318359C Polymeric compounds and methods of formulating same |
| 03/30/2004 | CA2305933C (poly)thia-alcynoic compounds and their derivatives, compositions containing them and their uses |
| 03/30/2004 | CA2291222C Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 03/30/2004 | CA2215470C Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 03/30/2004 | CA2117321C Stable cosmetic or dermatologic oil-in-water emulsion composition containing at least one vegetable oil comprising at least 40 % of linoleic acid triglycerides |
| 03/25/2004 | WO2004024766A1 Kdr peptides and vaccines containing the same |
| 03/25/2004 | WO2004024695A1 Novel molecules derived from noraporphine |
| 03/25/2004 | WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004024185A1 Drug or cosmetic |
| 03/25/2004 | WO2004024169A1 Composition comprising an abrasive agent for treating insect bites |
| 03/25/2004 | WO2004024144A1 Method of treating skin disorders |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2004024108A1 Orally administrable composition for improving hair and coat quality |
| 03/25/2004 | WO2004024106A2 Use of a cosmetic care product containing urea and cosmetic care product containing urea |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024060A2 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 03/25/2004 | WO2004023897A1 Composition containing in combination at least one gourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2004013134A3 Compounds |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2003086329A8 Skincare compositions comprising anti-oxidant agents |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003084565A3 Ve-ptp as regulator of ve-cadherin mediated processes or disorders |
| 03/25/2004 | WO2003082271A3 Indole derivatives having anti-angiogenetic activity |
| 03/25/2004 | WO2003080624A3 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003072060A3 Polypeptide formulation |
| 03/25/2004 | WO2003064458A3 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 03/25/2004 | WO2003063805A3 Cosmetic or dermatological use of vitamin a or the esters thereof in combination with a partly methylated beta-cyclodextrin |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003016351A3 N - cam related compounds modulating cell groth |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2002074290B1 Dermatological preparations containing a nsaid |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040059144 Aspirin-triggered lipid mediators |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059107 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; pharmaceutical formulations, improved cell and organ culture media, cryopreservation media, antiaging, chemoprotective and radioprotective uses |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058972 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058855 Use of materials having zinc ionophoric behavior |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058023 For inhibiting growth of acne bacterium Propionibacterium |
| 03/25/2004 | US20040057985 With sufficient release rates without needing any enhancer; oxybutynin of the droplet-shaped inner phase will not accumulate at the interfaces and surfaces of the matrix layer if certain polymers are used as pressure sensitive adhesive |
| 03/25/2004 | US20040057972 By adjusting the pH of the composition to between 6.5 and about 8.1 |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040057913 For therapy and prophylaxis of inflammatory due to ultraviolet radiation |
| 03/25/2004 | CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/24/2004 | EP1400579A2 Composition with anti-oxidative properties |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1400237A2 Use of a protectin activator to improve skin resistance |
| 03/24/2004 | EP1399579A1 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399472A2 Soluble heterodimeric cytokine receptor |
| 03/24/2004 | EP1399446A1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399188A2 Perylenequinones for use as photosensitizers and sonosensitizers |
| 03/24/2004 | EP1399184A2 Uses of mammalian genes and related reagents |
| 03/24/2004 | EP1399173A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor |
| 03/24/2004 | EP1399172A1 Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary and para-alimentary (food-supplements) products; their methods of preparation; their uses as preventive and/or as therapeutic agents |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist |